Braeburn
Agent42Agent Readiness: 42/100. Above median. Measured by StartupHub.ai. Median 41.Trust86Data Trust: 86/100. Top 25%. Measured by StartupHub.ai. Median 61.Develops long-acting implantable and injectable therapies for opioid addiction and chronic pain.
About this profileCompany details: from public sourcesFunding: no announced round on fileOwnership: not yet claimed by the companyScores: measured by named tools; each links to its methodOur rules
About
Braeburn Pharmaceuticals is focused on developing long-acting implantable and injectable therapies for opioid addiction and chronic pain. Their lead product, Probufine (buprenorphine implant), is FDA-approved for opioid dependence, and another product, CAM2038, is in the NDA refilling process for opioid dependence and in Phase 3 for pain management. The company aims to transform the management of opioid use disorder by eliminating stigma and improving access to treatment.
Listed competitors
Also in this space
Clinical-stage biopharmaceutical company developing treatments for brain and peripheral disorders involving the CB1 receptor.
Shares Biotechnology, Pharmaceuticals
AI-guided drug discovery platform for tissue-targeted medicines.
Shares Biotech, Drug Discovery
Biotechnology company developing immuno-neurology therapies for neurodegenerative diseases.
Shares Biotech, HealthTech
A global biotechnology company discovering, developing, manufacturing, and delivering innovative human therapeutics.
Shares Biotech, HealthTech
Cradle Bio B.V. is a Dutch, Swiss biotechnology company that develops software using machine learning for protein engineering. It was founded in 2021 and is base
Shares Biotech, HealthTech
A global oncology company developing and commercializing innovative cancer treatments.
Shares Biotech, HealthTech
Key facts
- Website
- braeburnrx.com
- Headquarters
- Plymouth Meeting, PA, United States
- Founded
- 2012
- Employees
- 276
- Total funding
- $133M (Conventional Debt)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 8 Jan 2018 | Conventional Debt | $110M | Wellington Management Company LLP |
| 1 Jan 2017 | Seed | $23M |
Tech stack
Detected on braeburnrx.com, last scanned 3 Nov 2026. Run your own scan
- Frontend
- jQuery, Bootstrap
- Analytics
- Google Tag Manager
- SEO
- Yoast SEO
- CMS / Builders
- WordPress
- CDN
- Cloudflare
- Email provider
- Microsoft 365
- Email marketing
- Adobe Marketo
- Cookie consent
- OneTrust
Braeburn scores 46. Does yours?
That is its Ahrefs DR: the backlink strength of a domain, on the Ahrefs 0 to 100 scale. Paste your website and you get yours in about a minute.
Frequently asked
Is Braeburn trustworthy and reputable?
StartupHub's Data Trust & Reputation score for Braeburn is 86 out of 100, a trusted rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.
How much funding has Braeburn raised?
Braeburn has raised a total of $133M in funding. The most recent round on record is Conventional Debt.
How many employees does Braeburn have?
Braeburn has approximately 276 people on record.
Public record
SEC filings, insider activity, nonprofit links and pay benchmarks for Braeburn
